Results 151 to 160 of about 50,237 (216)

Survival Outcomes in Metastatic Colorectal Cancer Patients with BRAF Mutations Undergoing Targeted Chemotherapy: A Reconstructed Individual Patient Data Meta-Analysis of Randomized Controlled Trials. [PDF]

J Gastrointest Cancer
Kazmi SK, Rehman MA, Tariq H, Kabir A, Ahmed J, Yee NSS.   +5 more
europepmc   +1 more source

Combination of oral fluoropyrimidines and EGFR-directed antibodies in frail patients with metastatic colorectal cancer: a systematic review. [PDF]

J Cancer Res Clin Oncol
Hasenburg AA, Stintzing S, Stahler A.
europepmc   +1 more source

Oncolytic Herpes Virus G47Δ Potentiates ADCC-Inducing Molecular Targeted Therapy via Coordinated Activation of Innate and Adaptive Immune Responses. [PDF]

Mol Cancer Ther
Nagatomo T, Iwai M, Tanaka M, Nishino H, Todo T.   +4 more
europepmc   +1 more source

Tangential flow filtration as a novel approach for fluorescent tracer purification and production up-scaling: cetuximab-800CW and ustekinumab-800CW as a proof-of-concept. [PDF]

MAbs
Huizinga HK, van Dijken RJ, Gareb B, Dekkers BGJ, van Zanten J, Westra HH, Koopmans P, Nagengast WB, Lub-de Hooge MN.   +8 more
europepmc   +1 more source

Targeting adaptive EGFR feedback enhances the therapeutic efficacy of RMC-6236 in cholangiocarcinoma. [PDF]

Exp Hematol Oncol
Yamazaki S, Hondo N, Yasukawa K, Kitazawa M, Nakamura S, Yamamoto Y, Miyazaki S, Tanaka H, Kuroiwa M, Ishizaka N, Shimizu T, Shimizu A, Soejima Y.   +12 more
europepmc   +1 more source

Internalization-Dependent EGFR-Targeted Photoactivation by Cetuximab-I21 Conjugates. [PDF]

J Immunother
Shang W, Shang H, Cai J, Vicky Q, Chen L, Wang H, Zhang X.   +6 more
europepmc   +1 more source

Fascin-1 expression in advanced colorectal cancer is associated with the treatment efficacy of cetuximab. [PDF]

Int J Clin Exp Pathol
Lu HJ, Lv GX, Ren GC, Shao JK, Wang CQ.
europepmc   +1 more source

High Resolution Ion Mobility Enables the Separation of α-Galactose Containing Glycans from Their Non-α-Galactose Isomers. [PDF]

J Biomol Tech
Park K, Orlando R.
europepmc   +1 more source

Circulating tumour DNA to guide rechallenge with cetuximab plus irinotecan in RAS/BRAF wild-type metastatic colorectal cancer: A nonrandomised clinical trial. [PDF]

Clin Transl Med
Wang DS, Chen WC, Ren C, Wang FH, Wang ZQ, Luo HY, Wang F, Tan Q, Li YH.   +8 more
europepmc   +1 more source

RAF/MEK clamp inhibition with avutometinib and cetuximab in RAF1 S257L-mutated, anti-EGFR-refractory metastatic colorectal cancer in Gaucher's disease. [PDF]

Oncologist
Rose A, Rosenberg A, Grewal US, Brown TJ, Hornstein N.   +4 more
europepmc   +1 more source